1.Diagnostic Value of Main Frequency of Transient Evoked Otoacoustic Emissions in Meniere's Disease
Wei QUO ; Suzhen ZHANG ; Xingqi LI
Journal of Audiology and Speech Pathology 1997;0(04):-
The purpose of this study was to assess the diagnostic value of main frequency of transient evoked otoacoustic emissions for Meniere's disease. The click- evoked transient otoacoustic emissions(TEOAE) in normal subjects and in patients with Meniere' s disease were examined using ILO 88 otodynamic analyzer system to observe the main frequency distrbution. The main frequeencies ranged from 1.2 to 1.6 kHz in normal ears, and from 0.8 to 1. 1 kHz in Meniere' s ears. The main frequency range of normal ears was obviously higher than that in Meniere's ears. After application of glycerol, the main frequencies in some Meniere's ears were shifted from relative low frequency range to relative high frequency range. TEOAE appeared in some Meniere's ears in which TEOAEs could not be evoked before application of glycerol. The results suggest that the TEOAE can be used in the diagnosis of Meniere's disease.
2.MULTIPLE BIOMARKER ASSAY IN PATIENTS WITH LUNG CANCER
Wei WAN ; Chuyi ZHANG ; Xianjian QUO ; Baoling MAO
Medical Journal of Chinese People's Liberation Army 1983;0(05):-
The levels of CEA, Lys, Fr and ?2-MG of serum and brochoalveolar lavage fluid (BALF) were determined in 99 patients with inflammatory lung diseases and 23 healthy subjects for controls. Their levels in BALF were compared between diseased and normal sides of lungs. The value of diagnosis of individual formulas was suggested. The combined ditermination of multiple biomarkers in serum and BALF can help to raise the positivity and spcificity of diagnosis of lung cancer.
3.Cylex ImmuKnow assay in Chinese stable liver transplant recipients
Jing LIU ; Shichun LU ; Menglong WANG ; Dongdong LIN ; Qingliang QUO ; Wei LAI ; Jing ZHANG ; Ning LI
Chinese Journal of Hepatobiliary Surgery 2011;17(5):383-385
Objective To identify the level of functional immunity as measured by the ImmuKnow assay in Chinese stable liver transplant recipients and to correlate these values with the dose and the trough levels of immunosuppressant, and with other clinical parameters of these patients. Methods Functional immune response was assessed by the ImmuKnow assay in 46 blood samples taken from 46 stable liver transplant recipients from Beijing Youan Hospital, Capital Medical University Liver Transplantation Center. Results The average ATP value in these stable liver transplant recipients was 203±114 ng/ml (range: 38.47 ATP ng/ml to 524.06 ATP ng/ml) at 22± 15 month post liver transplantation. There was no correlation either between ImmuKnow ATP values and the tacrolimus trough levels, or between ImmuKnow ATP values and the liver function (P<0. 05). Stepwise multiple regression analysis identified WBC and CD3+, CD3+ CD4+ as independent predictors of ImmuKnow assay levels when age, gender and underlying diagnosis were taken into account (P<0. 05). Five patients who were detected to have active HCV infection had lower ImmuKnow ATP values (<61 ng/ml). Conclusions The Cylex ImmuKnow assay ATP values were lower in Chinese stable liver transplant recipients compared with American patients. Further investigation is required to determine the role of the ImmuKnow assay in tailoring immunosuppressant therapy in liver transplant recipients.